ARTICLE | Company News
Active Biotech, Intellivax deal
June 5, 2000 7:00 AM UTC
The companies will develop a nasal spray vaccine to prevent Group A, B-hemolytic streptococci (GAS) infections. The collaboration will combine Intellivax's proteosome delivery platform with ACTI's GAS...